Molecular structure of Meloxicam sodium salt, CAS Number: 71125-39-8
Meloxicam sodium salt (CAS 71125-39-8)
See product citations (1)
Application:
Meloxicam sodium salt is a Cox-2 inhibitor
CAS Number:
71125-39-8
Molecular Weight:
373.38
Molecular Formula:
C14H12N3NaO4S2
Supplemental Information:
This is classified as a Dangerous Good for transport and may be subject to additional shipping charges.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.
QUICK LINKS
Ordering Information
Product Citations
Description
Technical Information
Safety Information
SDS & Certificate of Analysis
Meloxicam sodium salt is a compound that is particularly useful in biochemical assays to understand the inhibition of cyclooxygenase (COX) enzymes and the subsequent impact on prostaglandin synthesis. Researchers utilize this compound to investigate the molecular mechanisms underlying inflammation and pain at a cellular level. Additionally, the compound is applied in biochemical studies to explore the role of sodium salts in solubility and stability, which can influence the absorption and efficacy of certain compounds. It may also be used in comparative studies to assess the differences between various forms of meloxicam and their respective biological activities.
Meloxicam sodium salt (CAS 71125-39-8) References
- Removing the threat of diclofenac to critically endangered Asian vultures. | Swan, G., et al. 2006. PLoS Biol. 4: e66. PMID: 16435886
- Influence of ion-pairing and chemical enhancers on the transdermal delivery of meloxicam. | Zhang, JY., et al. 2009. Drug Dev Ind Pharm. 35: 663-70. PMID: 19259875
- Analysis of nine NSAIDs in ungulate tissues available to critically endangered vultures in India. | Taggart, MA., et al. 2009. Environ Sci Technol. 43: 4561-6. PMID: 19603677
- Characterization of a rat model of metastatic prostate cancer bone pain. | De Ciantis, PD., et al. 2010. J Pain Res. 3: 213-21. PMID: 21197325
- Estimation of multi-mycotoxin contamination in South African compound feeds. | Njobeh, PB., et al. 2012. Toxins (Basel). 4: 836-48. PMID: 23162700
- Development and in-house validation of an LC-MS/MS method for the quantification of the mycotoxins deoxynivalenol, zearalenone, T-2 and HT-2 toxin, ochratoxin A and fumonisin B1 and B2 in vegetable animal feed. | Åberg, AT., et al. 2013. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 30: 541-9. PMID: 23350851
- Optimization and pharmacological characterization of a refined cisplatin-induced rat model of peripheral neuropathic pain. | Han, FY., et al. 2014. Behav Pharmacol. 25: 732-40. PMID: 25325291
- Clinical efficacy and pharmacokinetics of meloxicam in Mediterranean buffalo calves (Bubalus bubalis). | Cagnardi, P., et al. 2017. PLoS One. 12: e0187252. PMID: 29077759
- Cisplatin increases the number of enterochromaffin cells containing substance P in rat intestine. | Obara, Y., et al. 2018. Naunyn Schmiedebergs Arch Pharmacol. 391: 847-858. PMID: 29766222
- Methocinnamox Produces Long-Lasting Antagonism of the Behavioral Effects of µ-Opioid Receptor Agonists but Not Prolonged Precipitated Withdrawal in Rats. | Gerak, LR., et al. 2019. J Pharmacol Exp Ther. 371: 507-516. PMID: 31439807
- Meloxicam affects the inflammatory responses of bovine mammary epithelial cells. | Caldeira, MO., et al. 2019. J Dairy Sci. 102: 10277-10290. PMID: 31447141
- Nonsteroidal anti-inflammatory drugs affect the mammary epithelial barrier during inflammation. | Sintes, GF., et al. 2020. J Dairy Sci. 103: 10742-10753. PMID: 32896404
- Nicotine-induced C-shape movements in planarians are reduced by antinociceptive drugs: Implications for pain in planarian paroxysm etiology? | Kim, A. and Rawls, SM. 2022. Brain Res. 1778: 147770. PMID: 34979130
Inhibitor of:
Cox-2.Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Meloxicam sodium salt, 100 mg | sc-215294 | 100 mg | $219.00 |